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Neuregulins are a family of growth factors that have been shown to promote the growth or differentiation of various cell
types. Recently, targeted mutations of the genes for neuregulins or their putative receptors by homologous recombination
resulted in embryonic lethality characterized by cardiac malformation. Here we investigate a role for neuregulin in the
growth of cultured chick heart cells. Neuregulin induced the tyrosine phosphorylation of a 185-kDa protein in cultured
heart cells, and it also stimulated an increase in [3H]thymidine incorporation and BrDU labeling in the cell cultures.
mmunocytochemistry revealed that the increased DNA synthesis was primarily in mesenchymal cells and not detected in
yocytes or endocardial cells. These data suggest that neuregulin may function as a paracrine signal in mesenchymal–
ndothelial interactions during cardiac development. © 1999 Academic Press
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(INTRODUCTION
The neuregulins are a family of multipotent growth
factors (Fischbach and Rosen, 1997) that include acetylcho-
line receptor inducing activities (ARIAs) (Falls et al., 1993),
lial growth factors (GGFs) (Marchionni et al., 1993),
eregulins (Holmes et al., 1992), and neu differentiation
actors (NDFs) (Peles et al., 1992). Neuregulin effects appear
o be mediated by interaction with a class of tyrosine kinase
eceptors related to the epidermal growth factor (EGF)
eceptor which includes erbB2, erbB3, and erbB4 (Burden
nd Yarden, 1997). The erbB receptors are receptor tyrosine
inases of 180–185 kDa that become phosphorylated upon
igand binding (Burden and Yarden, 1997). Neuregulins
timulate the tyrosine phosphorylation of these receptors
nd the subsequent activation of various signal transduc-
ion mechanisms. Neuregulins are synthesized as trans-
embrane precursors (proneuregulins) consisting of either
n immunoglobulin-like or cysteine-rich domain, an EGF-
1 Current address: National Institute of Mental Health, National
Institutes of Health, 9600 Rockville Pike, Bethesda, MD 20892.
2 Current address: Department of Neurology & Center for Mo-
ecular Medicine and Genetics, Wayne State University School of
edicine, 421 East Canfield Avenue, Detroit, MI 48201.
3 Current address: National Institute of Neurological Diseasend Stroke, National Institutes of Health, 9600 Rockville Pike,
ethesda, MD 20892.
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All rights of reproduction in any form reserved.ike domain, a transmembrane domain, and a cytoplasmic
ail (Fischbach and Rosen, 1997). The EGF-like domain of
euregulin appears to be sufficient for activation of erbB
eceptors and downstream signal transduction pathways
Holmes et al., 1992).
Several lines of evidence suggest that neuregulins are
nvolved in cardiac development. Neuregulin transcripts
ave been detected in the endocardium of mouse (Kramer et
l., 1996; Meyer and Birchmeier, 1995) and rat hearts
Corfas et al., 1995). ErbB receptors are present in the
myocardium and in mesenchymal cells of the endocardial
cushions (Gassmann et al., 1995; Lee et al., 1995; Meyer
and Birchmeier, 1995). Targeted mutations of neuregulin
and its receptors in mice by homologous recombination
were shown to result in embryonic lethality associated
with severe defects in ventricular trabeculation and endo-
cardial cushion formation in the heart (Erickson et al.,
1997; Gassmann et al., 1995; Kramer et al., 1996; Lee et al.,
1995; Meyer and Birchmeier, 1995). Mice lacking the gene
for neuregulin or its receptors erbB2 and erbB4 died in utero
and lacked ventricular trabeculae in the developing heart
(Gassmann et al., 1995; Kramer et al., 1996; Lee et al., 1995;
Meyer and Birchmeier, 1995). Neuregulin and erbB3 knock-
out mice displayed severe defects in endocardial cushion
and valve formation (Erickson et al., 1997; Meyer and
Birchmeier, 1995). The endocardial cushion and outflow
tract were reduced in size and lacked mesenchymal cells.
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140 Ford, Loeb, and FischbachNeuregulins have been shown to promote proliferation of
glial cells (Minghetti et al., 1996), Schwann cells (Dong et
l., 1997; Levi et al., 1995; Morrissey et al., 1995), keratin-
ocytes (Marikovsky et al., 1995), and mammary epithelial
cells (Marte et al., 1995). Therefore, we suspected that
euregulins may stimulate proliferation of cardiac myo-
ytes or endocardial cushion mesenchymal cells.
In this study, we investigated the prospect that neuregu-
in could promote the proliferation of embryonic heart cells
n vitro using the well-characterized chick embryo system
s our model. The EGF-like domain neuregulin b1 (EGF-b1)
nduced the phosphorylation of a 185-kDa protein in chick
eart cell cultures. EGF-b1 also stimulated DNA synthesis
in the heart cell cultures. Immunocytochemistry revealed
that the increased DNA synthesis was in nonmyocyte
mesenchymal cells, whereas little or no increased DNA
synthesis was observed in myocyte-enriched cultures in
response to EGF-b1 treatment. These data suggest that
euregulins play a crucial role in mesenchymal–
ndothelial interactions during cardiac development.
MATERIALS AND METHODS
Materials. Recombinant EGF-like domain of neuregulin b1
(residues 177–244; EGF b1) was from Amgen (Thousand Oaks, CA).
ecombinant EGF-like domain of neuregulin a (EGF a) was pur-
hased from R&D Systems (Minneapolis, MN). Antibodies for von
illebrands factor (VWF), vimentin, smooth muscle actin (SMA),
nd sarcomeric a actinin (aSA) and general chemicals were ob-
tained from Sigma Chemical Company (St. Louis, MO). Anti-
myosin heavy chain (MF-30) was from Developmental Studies
Hybridoma Bank (Iowa City, IA). Anti-erbB receptor antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-phosphotyrosine monoclonal antibody 4G10 was a gift from
Dr. Tom Roberts (Harvard Medical School). Chemiluminescence
reagents, [3H]leucine, and [3H]thymidine were purchased from New
ngland Nuclear (Boston, MA). Media, trypsin, antibiotics, and
erum were purchased from GIBCO BRL (Grand Island, NY).
In situ hybridization. In situ hybridizations were carried out as
reviously described (Falls et al., 1993). Hearts were fixed in 4%
araformaldehyde overnight at 4°C. After fixation, tissues were
lowly dehydrated and embedded in paraffin. Serial sagittal or
oronal sections (9 mm) were collected on gelatinized glass micro-
cope slides. Hybridization with sense and antisense probes were
arried out at 52°C for 18 h in 50% deionized formamide, 0.3 M
aCl, 20 mM Tris–HCl, pH 7.4, 5 mM EDTA, 10 mM sodium
hosphate, 10% dextran sulfate, 13 Denhardt’s solution contain-
ng total yeast RNA (50 mg/ml) and 35S-labeled RNA probe (3.5 3
104 cpm/ml) corresponding to base pairs 15–344 of the full-length
chicken proARIA sequence as described previously (Falls et al.,
1993). Slides were washed with 50% formamide, 23 standard
aline citrate (SSC), 10 mM dithiothreitol at 65°C, treated with
Nase A, and then washed at 37°C for 15 min each in 23 SSC and
.13 SSC. Sections were dehydrated rapidly, processed for autora-
iography with NTB-2 Kodak emulsion, exposed for 2 weeks at
°C, and examined by both light- and dark-field illumination.
Heart cell cultures. Cultures of embryonic chick heart cells
ere prepared as previously described (Siegel and Fischbach, 1984)
ith slight modifications. Briefly, three or more hearts were
Copyright © 1999 by Academic Press. All rightemoved aseptically from embryonic day 5 (E5) to E14 chick
mbryos. The hearts were pooled, minced and subjected to trypsin
0.01% in PBS) digestion at 37°C. Three to four digestions, each
asting a period of 10 min, were performed. The supernatant of each
igestion was transferred to a tube containing fetal calf serum (FCS)
nd fresh trypsin was added to the remaining tissue. For E14
issues, the first digest was discarded. Dissociated cells were
ooled, centrifuged, and resuspended in 10 ml of chick heart
edium (CHM; minimum essential medium without glutamine
MEM) containing Earle’s salts, 10% FCS (v/v), 50 U penicillin, and
0 mg/ml streptomycin). Cells were plated at a density of 100,000–
50,000 cells/cm2 in collagen-coated plates for 4–6 days. To isolate
onmyocyte mesenchymal cells, dissociated cells were preplated at
igh density (250,000 cells/cm2) for 60 min in uncoated 100-mm
issue-culture-treated dishes (Costar, Cambridge, MA). Unattached
ells (primarily myocytes) were removed and plated on collagen
Collaborative Research, Bedford, MA) at 100,000–150,000 cells/
m2. Attached cells (nonmyocyte mesenchymal cells) were rinsed
with MEM and CHM was added. All cultures were incubated at
37°C in a 5% CO2 environment. All cultures were incubated 4–6
ays prior to use. Attached cells were passaged after attaining
onfluence using trypsin/EDTA and plated on tissue culture plastic
200,000 cells/cm2). These cells were used 1–2 days after harvesting
and replating. For immunofluorescent studies, cells were plated in
collagen-coated or uncoated permanox coverslips (Newton, NC).
Immunoblotting. The plating medium was removed and the
cells were treated with neuregulin (in CHM containing 0.1% FCS)
for 45 min. Reactions were terminated by placing the cells on ice,
aspirating the medium, and adding ice-cold lysis buffer (50 mM
Tris, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 0.5%
Nonidet P-40, 1 mM sodium orthovanadate, 1 mM phenylmeth-
anesulfonyl fluoride, pH 8.0) for 30 min at 4°C. Harvested lysates
were denatured with loading buffer, resolved in SDS/5% polyacryl-
amide gels and transferred to polyvinylidene difluoride (PVDF)
membranes (Millipore Corp., Bedford, MA). Membranes were
blocked with 3% nonfat dry milk in phosphate-buffered saline–
0.05% Tween 20 (PBST) and exposed to primary antibodies diluted
in blocking buffer overnight at 4°C. After washing with PBST,
membranes were exposed to peroxidase conjugated secondary an-
tibodies for 1 h or more. Membranes were subsequently washed,
incubated with chemiluminescence reagents, and exposed to X-ray
film.
Precursor incorporation assays. Heart cell cultures were
treated with the indicated concentrations of neuregulin for 18–24
hr at 37°C. The solutions were removed and either low serum
(0.1%) CHM containing [3H]thymidine (1 mCi/ml) or leucine-free
ulbecco’s modified Eagle’s medium containing [3H] leucine (5
mCi/ml) was added for 4 h at 37°C. At the end of the incubation,
cells were fixed with methanol at 220°C for 10 min. Cells were
then washed three times with 10% trichloroacetic acid and lysed
with 0.1 M NaOH/0.1% sodium deoxycholate. Lysates were trans-
ferred to vials containing scintillant and vigorously vortexed.
Radioactivity was measured by liquid scintillation counting.
BrDU incorporation and immunohistochemistry. Heart cell
cultures were treated with neuregulin for 24 h and subsequently
incubated with 100 mM bromodeoxyuridine for 18–24 h. Cells were
fixed and permeabilized with methanol/acetone (1:1) for 10 min at
220°C. For BrDU labeling, cells were treated with 2 N HCl for 20
min and 0.1 N sodium borate (pH 8.5) for 10 min after fixation.
Primary antibodies were applied to cells overnight at 4°C in a
humidified chamber. BrDU incorporated into DNA was detected
using a mouse anti-BrDU antibody (Oncogene Science, Cambridge,
s of reproduction in any form reserved.
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141Neuregulin Stimulates DNA Synthesis in Heart CellsMA). Slides were washed twice in PBS and then incubated in
secondary antibodies coupled to Cy3 for 1 h at room temperature.
lides were washed and mounted using 5% propylgallate in 50%
lycerol as an antifade agent and visualized with epifluorescence.
RESULTS
Neuregulin Is Expressed in Embryonic Chick Heart
We examined the expression of neuregulin in E5 to E14
chick embryos by in situ hybridization using a full-length
chicken proARIA sequence (Falls et al., 1993). Neuregulin
mRNA was associated with the endocardial endothelium of
hearts at all embryonic ages examined ranging from E5 to
FIG. 1. In situ hybridization of neuregulin-1 in a cross-section of
f five individual embryos. Neuregulin mRNA is expressed in the
ndothelial lining of the endocardial cushion (asterisks). Intense s
orsal root ganglia, and dermatomyotome (arrowhead). No labelinE14 (Figs. 1–3). Similar expression patterns for neuregulin
have been demonstrated in embryonic rat and mouse hearts
Copyright © 1999 by Academic Press. All rightover more limited age ranges (Corfas et al., 1995; Kramer et
al., 1996; Meyer and Birchmeier, 1995). At E5, neuregulin
mRNA was detected in both the atrial and ventricular
endothelium (Fig. 1a). Particularly intense labeling was
evident in the endothelial lining of the endocardial cush-
ions of the atrioventricular canal and outflow tract. Neu-
regulin mRNA was also detected in other areas in the E5
chick embryo. The greatest level of neuregulin mRNA was
detected in the motor neurons of the spinal cord and dorsal
root ganglia. Labeling was also observed in the dermato-
myotome and aorta. No mRNA was observed in the E5
embryo using a sense control probe (Fig. 1b). At E8, neu-
regulin expression was still prevalent in the endothelial
lining of the heart chambers (Fig. 2a). Intense labeling was
bryonic day 5 (E5) chick (a). Figures 1a and 1b are representations
ocardium of the chambers (A, atrium; V, ventricle) as well as the
ng is also observed in the aorta (arrow) as well as the spinal cord,
resent in the sense control (b). Bar, 500 mm.an em
endalso observed in the endothelial lining of major blood
vessels. In older hearts (E11 and E14), neuregulin mRNA
s of reproduction in any form reserved.
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142 Ford, Loeb, and Fischbachwas expressed throughout the endocardium but was most
FIG. 2. In situ hybridization of neuregulin-1 in (E8-14) chick hea
mRNA is expressed in the endothelial lining of hearts at all ages e
also noted (arrow). The endothelial lining of the endocardial cush
mRNA expression was observed at E11 (b) and E14 (c, d). Neuregul
valves (asterisks). The inset in (c) is a higher magnification of a deintense in the endothelial lining of developing valves (Figs.
2b–2d). Vascular endothelial labeling persisted throughout
t
r
Copyright © 1999 by Academic Press. All rightmbryogenesis, although blood vessels were removed prior
epresentations are of three or more individual hearts. Neuregulin
ined (a–d). At E8 (a), intense labeling of the major blood vessels is
also heavily labeled (asterisks). Similar endothelial neuregulin-1
mRNA is concentrated in the the endothelial lining of developing
ing valve at E14. Bar, 500 mm (a, b), 400 mm (c), and 200 mm (d).rt. R
xam
ion iso preparing the sections presented here. In addition, neu-
egulin mRNA in the myocardium was observed in the E14
s of reproduction in any form reserved.
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143Neuregulin Stimulates DNA Synthesis in Heart Cellsheart (Fig. 3a) most highly concentrated in the apical region
of the heart. Myocardium labeling was not as great when a
sense control probe was used (Fig. 3b). The observation of
specific neuregulin labeling in the myocardium over back-
ground indicates that neuregulin is expressed either in the
myocardial myocytes or the microvascular endothelium
within the myocardium. More experiments are necessary to
determine cell-type-specific expression of neuregulins in
the heart. The results of this study are consistent with
earlier suggestions that neuregulin is involved in cardiovas-
cular development and in the formation of the endocardial
cushions and valves.
Neuregulin Stimulates Mitogenesis in Heart Cells
To determine whether neuregulin was mitogenic in heart
cell cultures, we examined [3H]thymidine incorporation
after 20–24 h treatment with the EGF-like domain of the b1
soform of the neuregulins (EGF b1). EGF-b1 stimulated an
ncrease in [3H]thymidine incorporation in E14 heart cell
ultures (Fig. 4). EGF b1 (1 nM) reproducibly stimulated
[3H]thymidine incorporation in cells 1.5- to 2-fold. Experi-
ents performed with the full-length extracellular domain
f neuregulin b1 (residues 1–244) also increased [3H]thymi-
ine incorporation in E14 heart cells (data not shown).
mall increases in [3H]thymidine incorporation were ob-
erved in earlier embryonic heart cell cultures following
GF b1 treatment.
The EGF-like domain of neuregulin is expressed as two
ajor forms, the a and b isoforms (Burden and Yarden, 1997;
Fischbach and Rosen, 1997). We examined [3H]thymidine
incorporation in heart cell cultures following treatment with
EGF b1 and the EGF-like domain of neuregulin a (EGF a).
FIG. 3. In situ hybridization of neuregulin-1 in (E14) chick
ventricle. Representations are of three or more individual hearts.
Neuregulin mRNA is expressed in the apical region of the ventric-
ular myocardium (a). Background labeling is present but dramati-
cally reduced in the sense control (b). Bar, 200 mm.Both EGF-b1 and EGF-a stimulated a concentration-
ependent increase in [3H]thymidine incorporation in E14
Copyright © 1999 by Academic Press. All rightheart cell cultures (Fig. 5a). EGF-b1-stimulated [3H]thymidine
ncorporation yielded a half-maximal response at ;0.1 nM,
hereas EGF a was inactive at concentrations lower than 10
M. EGF-b1 was also more potent than EGF a. Higher
oncentrations of EGF-b1 or EGF-a slightly inhibited [3H]thy-
idine incorporation in the heart cell cultures. This phenom-
non may reflect receptor downregulation or low-affinity
nteractions with other receptors. The stimulated [3H]thymi-
ine incorporation in response to EGF b1 we observed was
nearly twofold greater than the maximal effect obtained with
EGF a (Figs. 5a, b). The concentration of EGF-b1 effective in
stimulating heart cell mitogenesis is similar to those shown to
induce proliferation of Schwann cells, keratinocytes, and
mammary epithelial cells (Dong et al., 1997; Levi et al., 1995;
Marikovsky et al., 1995; Marte et al., 1995; Morrissey et al.,
995). No significant difference in protein synthesis was
bserved in these cultures following neuregulin treatment as
etermined by [3H]leucine incorporation (data not shown).
We examined receptor tyrosine phosphorylation follow-
ng treatment with EGF-b1 and EGF-a. A band of ;185 kDa
(p185) was detected by Western blot analysis in lysates of
cells treated with EGF-b1, using an anti-phosphotyrosine
antibody (Fig. 5c). A band of the same molecular weight was
also seen when cells were treated with EGF-a, although a
00-fold higher concentration (100 nM) was required to
timulate p185 phosphorylation in these cells. In addition,
he level of p185 phosphorylation detected following
GF-b1 treatment (1 nM) was greater than that of EGF-a
(100 nM)-stimulated phosphorylation. These results are
consistent with the [3H]thymidine incorporation experi-
ments.
We investigated the ability of neuregulin to stimulate
DNA synthesis in myocyte and non-myocyte-enriched cul-
tures. We separated myocytes from nonmyocytes by differ-
ential adhesion as described above. Nonmyocytes (mesen-
chymal cells) more rapidly adhere to tissue culture plastic
than myocytes (Simpson and Savion, 1982). Figures 6a and
6b show cultures of myocyte-enriched and non-myocyte-
enriched cultures, respectively. Myocyte cultures produced
semiconfluent, contact-inhibited monolayers consisting of
mainly spindle-shaped cells. In contrast, nonmyocyte cul-
tures formed layers of polygonal, overlapping cells reminis-
cent of smooth muscle cells in culture (Owens, 1995). Many
beating cells were present in myocyte-enriched cultures,
while beating cells were seldom seen in non-myocyte-
enriched cultures.
Immunocytochemistry revealed that the cells that did
not attach during the preplating stained for a-sarcomeric
actinin, myosin heavy chain, and desmin, indicating the
presence of myocytes (Figs. 6c, 6e, and 6g). Smooth muscle
cells are also present in these cultures as demonstrated by
smooth muscle actin (SMA) immunostaning (data not
shown). Greater that 95% of cells that remained attached
after preplating were labeled by the mesenchymal cell
marker, vimentin (Fig. 6h). Most of these cells (.80%)
stained for SMA (Fig. 6f). This is consistent with a report
demonstrating that chick endocardial cushion mesenchy-
s of reproduction in any form reserved.
N
e
i
U
f
i
i
e
a
2
s
o
fi
m
l
8
i
g
imen
p * den
144 Ford, Loeb, and Fischbachmal cells express SMA in vitro (DeRuiter et al., 1997;
akajima et al., 1997). Less than 1% of non-myocyte-
nriched cell cultures stained for a-sarcomeric actinin (Fig.
6d). Endothelial cells were seldom detected in either culture
as indicated by the absence of Von Willebrand’s Factor
staining (data not shown).
Surprisingly, EGF-b1 did not stimulate [3H]thymidine
ncorporation in E14 myocyte-enriched cultures (Fig. 7).
nder the same conditions, 10% FCS stimulated a three-
old increase in [3H]thymidine incorporation, suggesting
that the failure of EGF-b1 to stimulate [3H]thymidine
incorporation is not due to limited proliferative potential of
the cell culture. On the other hand, EGF-b1 consistently
nduced a two- to threefold increase in [3H]thymidine
incorporation in E14 non-myocyte-enriched cultures (Fig.
7). Neuregulin also stimulated increased [3H]thymidine
ncorporation in earlier embryonic (E5–E11) non-myocyte-
nriched cultures.
In addition to [3H]thymidine incorporation, mitogenic
ctivity was assessed by treatment of cells with EGF-b1 for
4 h followed by exposure to BrDU. Cells were fixed and
tained with an anti-BrDU monoclonal antibody. Analysis
FIG. 4. Mitogenic response of heart cells to neuregulin-1. Dissoci
rown for 4–6 days. E5 (n 5 3), E8 (n 5 3), E11 (n 5 2), and E14 (n
nM) and [3H]thymidine incorporation was measured. Each exper
erformed in each experiment. Data analyzed by Student’s t test (f BrDU incorporation into nuclei in E14 cultures con-
rmed that neuregulin induced DNA synthesis in non-
Copyright © 1999 by Academic Press. All rightyocyte-enriched cultures (Figs. 8a and 8b). No BrDU
abeling was detected in myocyte-enriched cultures (Figs.
c and 8d). In the nonmyocyte cultures, 15–20% of the cells
ncorporated BrDU into their nuclei in response to EGF-b1
compared to 5–8% of cells labeled in controls.
ErbB Receptor Expression in Heart Cell Cultures
To determine whether erbB receptors were expressed in
chick heart cell cultures, immunoblotting with antibodies
specific for ErbB-2, ErbB-3, and ErbB-4 was performed.
ErbB-2, ErbB-3, and ErbB-4 were detectable in lysates of
myocyte-enriched cultures (Fig. 9). ErbB2 was prominently
detected in nonmyocyte cultures, while only a faint ErbB-3
band was observed. No ErbB-4 immunoreactivity was de-
tected in nonmyocytes. The expressed receptors were not
downregulated in either culture after 24 h treatment with
neuregulin (not shown).
DISCUSSION
cells from E5–E14 chick hearts were plated at similar density and
8) cultures were subsequently treated for 20–24 h with EGF-b1 (1
t (n) represents an individual plating with triplicate treatments
otes P , 0.05).ated
5 1In this study we investigated whether neuregulin was
capable of stimulating a proliferative response in chick
s of reproduction in any form reserved.
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medium (lane 1), 1 nM EGF-b1 (lane 2), or the indicated concen-
trations of EGF-a (lanes 3–5) in E14 cells.
145Neuregulin Stimulates DNA Synthesis in Heart Cells
Copyright © 1999 by Academic Press. All rightheart cells and whether neuregulin was expressed at the
proper place and time to mediate cardiac morphogenesis.
We examined the expression of neuregulin in E5 to E14
chick embryos by in situ hybridization using a full-length
chicken proARIA sequence (Falls et al., 1993) Neuregulin
expression was observed in the endocardium of chick hearts
throughout development. Neuregulin was heavily ex-
pressed in the endocardial endothelium lining the endocar-
dial cushions of the atrioventricular canal and outflow tract
and developing valves. Neuregulin also strongly labeled the
endothelium of the major blood vessels. These findings are
consistent with observations of neuregulin expression in
embryonic rat and mouse hearts (Corfas et al., 1995; Kramer
et al., 1996; Meyer and Birchmeier, 1995). Interestingly, as
the myocardium increased in mass during development,
myocardial expression of neuregulin was observed. It is
unclear whether neuregulin is expressed in the myocardial
myocytes or the microvascular endothelium within the
myocardium. A recent report demonstrated neuregulin
mRNA expression in cultured rat cardiac microvascular
endothelial cells (Zhao et al., 1998). However, the diffuse
labeling throughout the myocardium suggests that neu-
regulin mRNA may be expressed in cardiac myocytes as
well. Neuregulin mRNA has been detected in chick skel-
etal muscles (Meier et al., 1998; Ng et al., 1997; Pun and
Tsim, 1995), cultured mouse muscle cells (Moscoso et al.,
1995), and in the myotome of embryonic Xenopus (Yang et
al., 1998) and embryonic chick (Loeb et al., 1999). The role
of muscle-derived neuregulin in skeletal myogenesis is not
known.
Recently, two additional neuregulin-like genes, termed
neuregulin-2 (Busfield et al., 1997; Carraway et al., 1997;
Chang et al., 1997) and neuregulin-3 (Zhang et al., 1997),
were cloned. In embryonic rodent hearts, neuregulin-1,
which includes ARIA, GGF, heregulin, and NDF, is primar-
ily expressed in the ventricular endocardium, while
neuregulin-2 is predominant in the atrium. Neuregulin-3
mRNA was not detected in heart tissues. The expression of
neuregulin-2 in chick heart and its role in cardiac develop-
ment remain unknown.
Neuregulin-stimulated DNA synthesis in cultured chick
heart cells as shown by an increase in [3H]thymidine
ncorporation following EGF-b1 treatment. EGF-b1 stimu-
lated a concentration-dependent increase in [3H]thymidine
incorporation in E14 heart cell cultures although the mito-
genic response to EGF b1 was 2-fold higher than the
maximal effect obtained with EGF a. Preliminary results
from our laboratory demonstrate that mRNA for both a and
b isoforms of neuregulin is expressed in embryonic chick
hearts (K. Rosen, personal communication). EGF-b1 did not
timulate [3H]leucine incorporation, thus suggesting that
EGF-b1 does not induce hypertrophic growth in the cells.
To determine which subpopulation of heart cells was
esponsive to neuregulin, we separated E14 myocytes from
onmyocytes by differential adhesion and analyzed [3H]thy-FIG. 5. (a) E14 cell cultures were treated with the indicated
concentrations of EGF-a and EGF-b1 for 20–24 h and [3H]thymi-
dine incorporation was measured. (b) E14 cell cultures were treated
with 100 nM EGF-a or 1 nM EGF-b1 for 20–24 h and [3H]thymidine
incorporation was measured (n 5 8; * denotes P , 0.05; one-way
NOVA). (c) Neuregulin promotes the tyrosine phosphorylation of
185-kDa protein in cultured E14 chick heart cells. Phosphoty-
osine immunoblots of heart cells treated for 45 min with control
idine incorporation following EGF-b1 treatment. To our
surprise, EGF-b1 stimulated a two- to threefold increase in
s of reproduction in any form reserved.
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146 Ford, Loeb, and FischbachFIG. 6. Characterization of heart cell cultures. E14 Myocyte-enriched (a, c, e, g) and non-myocyte-enriched cultures (b, d, f, h) were fixed
nd stained for sarcomeric actinin (c, d), myosin heavy chain (e), smooth muscle actin (f), desmin (g), and vimentin (h). Myocyte-enriched
a) and non-myocyte-enriched (b) cultures are shown using phase-contrast microscopy; 203 magnification).
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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147Neuregulin Stimulates DNA Synthesis in Heart Cells[3H]thymidine incorporation in E14 non-myocyte-enriched
ultures. EGF-b1 did not stimulate [3H]thymidine incorpo-
ation in E14 myocyte-enriched cultures. Analysis of BrDU
ncorporation into nuclei in E14 cultures confirmed that
GF-b1 induced DNA synthesis in non-myocyte-enriched
ultures. Similar effects of EGF-b1 were observed in earlier
mbryonic cultures.
Greater that 95% of cells in nonmyocyte cultures were
abeled with an antibody raised against the mesenchymal
ell marker, vimentin. Most of these cells also expressed
MA. SMA expression has been demonstrated in avian
ndocardial cushion mesenchymal cells in vitro and in
ivo (DeRuiter et al., 1997; Nakajima et al., 1997). Taken
ogether, these results indicate that EGF-b1 is a potent
itogen for nonmyocyte heart mesenchymal cells based
n its ability to induce cells to incorporate [3H]thymidine
r BrDU into their nuclei. However, only a fraction of
ells in the nonmyocyte cultures responded to EGF-b1.
The inability of EGF-b1 to induce a majority of cells to
enter S phase suggests that cells are heterogenous in their
response to EGF-b1. The reason for this heterogeneity in
esponsiveness to EGF-b1 remains unclear but may be
related to the presence of multiple sources of nonmyo-
FIG. 7. Mitogenic response of heart cells to neuregulin-1. Myocyte
h with EGF-b1 (1 nM) and [3H]thymidine incorporation was measu
treatments performed in each experiment (myocyte, n 5 7; nonmycyte mesenchymal cells in developing mammalian
hearts. Endocardial-derived mesenchyme contributes to
1
m
Copyright © 1999 by Academic Press. All righthe formation of the valves and septum, while the coro-
ary vasculature develops from noncardiac mesodermal
esenchyme (Baldwin, 1996). Mesenchymal cells from
he neural crest gives rise to vascular smooth muscle
ells and contribute to the formation of the aorticopul-
onary septum (Kirby and Waldo, 1995). Specific mark-
rs for the different subtypes of mesenchymal cells
nvolved in cardiovascular development have not been
dentified. However, erbB3 has been demonstrated in
ndocardial cushion mesenchymal cells and migrating
eural crest cells (Erickson et al., 1997; Meyer and
irchmeier, 1995). The presence of erbB3 receptors and
MA immunoreactivity (DeRuiter et al., 1997; Nakajima
t al., 1997) in cushion mesenchymal cells along with our
bservation that neuregulin stimulated DNA synthesis
n cardiac nonmyocytes suggests that neuregulins induce
roliferation of mesenchymal cells in the endocardial
ushions and outflow tract and may account for the
ardiac phenotype in neuregulin and erbB3 knockout
ice. Studies are underway to determine the role of
euregulins in septal and coronary vascular development.
Congenital malformations of the cardiovascular sys-
em are the most common human birth defects (Rossant,
nonmyocyte cultures from E14 chick hearts were treated for 20–24
ach experiment (n) represents an individual plating with triplicate
es, n 5 7). Data analyzed by Student’s t-test (* denotes P , 0.05).and996). The majority of heart defects result from abnormal
orphogenesis of valves and septa. Endocardial cushion
s of reproduction in any form reserved.
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148 Ford, Loeb, and Fischbachdevelopment is characterized by several events including
the endothelial–mesenchymal transformation (EMT) of
endocardial cells of the atrioventricular (AV) canal into
cushion mesenchymal cells. These cushion cells prolif-
erate and traverse the extracellular matrix in response to
signals from the adjacent myocardium and endocardium
and eventually differentiate into the connective tissues
of the valve leaflet and membranous septa. The precise
molecular mechanisms underlying endocardial cushion
formation are presently unknown, although some aspects
of the process in chick heart have been described using an
in vitro bioassay (Eisenberg and Markwald, 1995). An
EDTA particulate extract from AV extracellular matrix,
FIG. 8. Mitogenic response of E14 non-myocyte-enriched (a, b) an
0–24 h in the absence (a, c) or presence (b, d) of EGF-b1 (1 nM) and
ith an anti-BrDU antibody.termed ES 130, was shown to mimic the effects of AV
myocardial extracts on EMT (Krug et al., 1987, 1995). s
Copyright © 1999 by Academic Press. All rightransforming growth factor b (TGF b) has also been
hown to play a major role in endothelial–mesenchymal
nteractions during endocardial cushion formation in the
hick heart (Brown et al., 1996; Potts et al., 1991, 1992;
otts and Runyan, 1989; Runyan et al., 1992). TGF b, in
combination with a ventricular myocardial extract, pro-
duced EMT and cushion cell migration into the extracel-
lular matrix. These results presented herein clearly sug-
gest that neuregulins play a prominent role in the
development of the endocardial cushions and heart
valves. It is likely that neuregulins may either regulate
ES 130 and TGF b function or work in concert with them
uring endocardial cushion formation.
ocyte-enriched (c, d) cultures to EGF-b1. Cultures were treated for
ed for 18–24 h with 100 mM BrDU. Cultures were fixed and stainedd myRecently Zhao et al. (1998) suggested that neuregulins
timulate proliferation and promote survival in embryonic
s of reproduction in any form reserved.
B149Neuregulin Stimulates DNA Synthesis in Heart Cellsand neonatal rat myocytes. The discrepancy between this
report and our findings may reflect differences in species or
the developmental stages examined. In addition, they re-
ported that neuregulin did not stimulate proliferation in
neonatal nonmyocyte enriched cultures. This report is not
in conflict with our data when considering their studies of
erbB receptor mRNA expression in rat heart. They observed
that erbB2 and erbB4 are expressed in rat hearts throughout
gestation and in the adult. ErbB3 expression is, however,
restricted to early and midgestational rat hearts and is not
expressed in late embryonic and adult hearts. This implies
that erbB3-expressing cells (e.g., endocardial cushion mes-
enchymal cells) are transiently present in early embryonic
hearts which can respond to neuregulins. Thus, the non-
myocytes in the report of Zhao et al. (1998) probably
represent fibroblast and not endocardial cushion mesenchy-
mal cells.
Our data demonstrate that neuregulins do not induce
myocyte proliferation or hypertrophic growth in embryonic
chick heart cell cultures. Thus, the fact that neuregulin and
erbB receptor knockout mice lack ventricular trabeculae
cannot be easily explained by the results seen in chick heart
cultures. Neuregulins instead may influence myocyte dif-
ferentiation or maturation in chick heart. Neuregulin has
been shown to increase acetylcholine receptors and sodium
channels in skeletal muscle and thus may play similar roles
FIG. 9. Expression of neuregulin receptors in cardiac myocyte
and nonmyocyte cultures. Cell lysates of myocyte cultures (lane
1) and nonmyocyte cultures were prepared (lane 2). Proteins
were separated by SDS–PAGE and immunoblotting was per-
formed with antibodies raised against erbB-2 (a), erbB-3 (b), or
erbB-4 (c). These are representative immunoblots of three sepa-
rate experiments.in cardiac myocyte development (Corfas and Fischbach,
1993; Falls et al., 1993).
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